• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice.

作者信息

Soheili Tayebeh, Rivière Julie, Ricciardelli Ida, Durand Amandine, Verhoeyen Els, Derrien Anne-Céline, Lagresle-Peyrou Chantal, de Saint Basile Geneviève, Cosset François-Loïc, Amrolia Persis, André-Schmutz Isabelle, Cavazzana Marina

机构信息

Human Lymphohaematopoiesis Laboratory, INSERM U1163, Paris, France.

IMAGINE Institute, University of Paris Descartes-Sorbonne Paris Cité, Paris, France.

出版信息

Blood. 2016 Dec 15;128(24):2859-2862. doi: 10.1182/blood-2016-07-729871. Epub 2016 Oct 31.

DOI:10.1182/blood-2016-07-729871
PMID:27799161
Abstract
摘要

相似文献

1
Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice.基因校正的人类Munc13-4缺陷型CD8 + T细胞可有效抑制免疫缺陷小鼠中EBV驱动的淋巴细胞增殖。
Blood. 2016 Dec 15;128(24):2859-2862. doi: 10.1182/blood-2016-07-729871. Epub 2016 Oct 31.
2
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.4-1BB 缺陷导致的免疫缺陷和 EBV 诱导的淋巴组织增生。
J Allergy Clin Immunol. 2019 Aug;144(2):574-583.e5. doi: 10.1016/j.jaci.2019.03.002. Epub 2019 Mar 11.
3
Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.儿童系统性EB病毒阳性T细胞淋巴增殖性疾病伴噬血细胞综合征
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7110-3. eCollection 2014.
4
Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.人源外周血淋巴细胞-重症联合免疫缺陷小鼠中人类细胞植入的调控及EB病毒相关淋巴增殖性疾病的发展
J Immunol. 2000 Jul 1;165(1):518-27. doi: 10.4049/jimmunol.165.1.518.
5
Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.蚊虫叮咬超敏反应与爱泼斯坦-巴尔病毒感染相关噬血细胞性淋巴组织细胞增生症之间的免疫学差异。
PLoS One. 2013 Oct 18;8(10):e76711. doi: 10.1371/journal.pone.0076711. eCollection 2013.
6
Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.年轻和老年人群体中全身 EBV 阳性 T 细胞淋巴组织增生性疾病的临床病理特征。
Diagn Pathol. 2021 Jun 4;16(1):48. doi: 10.1186/s13000-021-01107-1.
7
Fulminant Epstein-Barr virus-driven CD8 positive T-cell lymphoproliferative disorder with chromosomal abnormality.伴有染色体异常的暴发性爱泼斯坦-巴尔病毒驱动的CD8阳性T细胞淋巴增殖性疾病
Pediatr Blood Cancer. 2011 Jul 15;57(1):182. doi: 10.1002/pbc.23122. Epub 2011 Mar 28.
8
The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease.翻译抑制剂西维因在保留针对EB病毒驱动的淋巴增殖性疾病的固有免疫和适应性免疫的同时，表现出直接的抗肿瘤活性。
Oncotarget. 2015 Feb 20;6(5):2693-708. doi: 10.18632/oncotarget.2098.
9
Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.TNFRSF7/CD27 中的新突变：人类 CD27 缺陷的临床、免疫和遗传特征。
J Allergy Clin Immunol. 2015 Sep;136(3):703-712.e10. doi: 10.1016/j.jaci.2015.02.022. Epub 2015 Apr 3.
10
[Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases].[爱泼斯坦-巴尔病毒（EBV）相关疾病中EBV特异性CD8 + T淋巴细胞的定量分析]
Rinsho Ketsueki. 2000 Jun;41(6):487-90.

引用本文的文献

1
Functional role of UNC13D in immune diseases and its therapeutic applications.UNC13D 在免疫性疾病中的功能作用及其治疗应用。
Front Immunol. 2024 Oct 14;15:1460882. doi: 10.3389/fimmu.2024.1460882. eCollection 2024.
2
Too much of a good thing: a review of primary immune regulatory disorders.过犹不及：原发性免疫调节紊乱综述。
Front Immunol. 2023 Oct 31;14:1279201. doi: 10.3389/fimmu.2023.1279201. eCollection 2023.
3
Advances in gene therapy for inborn errors of immunity.免疫遗传性缺陷的基因治疗进展。
Curr Opin Allergy Clin Immunol. 2023 Dec 1;23(6):467-477. doi: 10.1097/ACI.0000000000000952. Epub 2023 Oct 13.
4
Gene therapy for inborn errors of immunity: past, present and future.免疫缺陷性遗传病的基因治疗：过去、现在和未来。
Nat Rev Immunol. 2023 Jun;23(6):397-408. doi: 10.1038/s41577-022-00800-6. Epub 2022 Nov 25.
5
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH).过继性 T 细胞疗法可治愈活动期噬血细胞性淋巴组织细胞增生症（HLH）的小鼠。
EMBO Mol Med. 2022 Dec 7;14(12):e16085. doi: 10.15252/emmm.202216085. Epub 2022 Oct 24.
6
Gene Edited T Cell Therapies for Inborn Errors of Immunity.用于先天性免疫缺陷的基因编辑T细胞疗法
Front Genome Ed. 2022 Jun 16;4:899294. doi: 10.3389/fgeed.2022.899294. eCollection 2022.
7
Gene Therapy for Primary Immunodeficiency.原发性免疫缺陷的基因治疗
Hemasphere. 2020 Dec 29;5(1):e509. doi: 10.1097/HS9.0000000000000509. eCollection 2021 Jan.
8
Alternative Promoter Encodes a Functional Munc13-4 Isoform Predominantly Expressed in Lymphocytes and Platelets.替代启动子编码一种功能性 Munc13-4 异构体，主要在淋巴细胞和血小板中表达。
Front Immunol. 2020 Jun 9;11:1154. doi: 10.3389/fimmu.2020.01154. eCollection 2020.
9
Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by Genetic Defects.慢病毒基因治疗家族性噬血细胞性淋巴组织细胞增生症 3 型，由遗传缺陷引起。
Hum Gene Ther. 2020 Jun;31(11-12):626-638. doi: 10.1089/hum.2019.329.
10
Recent advances in primary immunodeficiency: from molecular diagnosis to treatment.原发性免疫缺陷的最新进展：从分子诊断到治疗
F1000Res. 2020 Mar 19;9. doi: 10.12688/f1000research.21553.1. eCollection 2020.